Tirzepatide, a secure GLP-1/GIP medication prescribed by doctors under various brand names, is a once-weekly injectable designed to regulate blood sugar levels. Initially intended for patients with type 2 diabetes, it exhibits promising potential as a weight-loss medication. Clinical trials have demonstrated the effectiveness of tirzepatide in reducing hemoglobin A1C levels and aiding in weight loss. Research suggests an approximate 22% reduction in total body weight without the strict reliance on diet or exercise.* At our clinic, Tirzepatide is prescribed at a significantly lower cost compared to retail pharmacy pricing. 12.5mg-15mg. Reserved for unique cases (applicable to less than 2% of patients).  Initial program 8-week supply for $1300. $600 a month thereafter until goals are reached.